Simultaneous occurrence of focal nodular hyperplasia and primary sclerosing cholangitis in a young female

European Journal of Gastroenterology and Hepatology

Volumn 12, Issue 5, 2000, Pages 565-567

  Gow, Paul John ^a   Chapman, Roger William ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Focal nodular hyperplasia; Liver lesion; Primary sclerosing cholangitis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMAGING; LIVER HISTOLOGY; NODULAR HYPERPLASIA; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

EID: 0034081766     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012050-00015     Document Type: Article

References (18)

1. 1 Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5:1194-1200.
2. 2 Sakatoku H, Hirokawa Y, Inoue M, Kojima M, Yabana T, Sakurai M. Focal nodular hyperplasia in an adolescent with glycogen storage disease type 1 with mesocaval shunt operation in childhood: a case report and review of the literature. Acta Paediatr Jpn 1996; 38:172-175.
3. 3 Harnois DM, Gores GJ, Ludwig J, Steers JL, LaRusso NF, Wiesner RH. Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol 1997; 27:512-516.
4. 4 Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21:870-877.
5. 5 Broome U, Lofberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995; 22:1404-1408.
6. 6 Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38:610-615.
7. 7 Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ Jr, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991; 213:21-25.
8. 8 Miros M, Kerlin P, Walker N, Harper J, Lynch S, Strong R. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation. Gut 1991; 32:1369-1373.
9. 9 Stieber AC, Marino IR, Iwatsuki S, Starzl TE. Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int Surg 1989; 74:1-3.
10. 10 Snook JA, Kelly P, Chapman RW, Jewell DP. Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis. Gut 1989; 30:243-245.
11. 11 Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997; 41:522-525.
12. 12 Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Metreau JM, Meignan M, et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 1995; 22:1674-1681.
13. 13 Mathieu D, Zafrani ES, Anglade MC, Dhumeaux D. Association of focal nodular hyperplasia and hepatic hemangioma. Gastroenterology 1989; 97:154-157.
14. 14 Soyer P, Bluemke DA, Reichle R, Calhoun PS, Bliss DF, Scherrer A, et al. Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma. Am J Roentgenol 1995; 165:1427-1431.
15. 15 Chen H, Hui Y. Intrahepatic peripheral cholangiocarcinoma: CT features in 18 pathologically proven cases. Chin Med J [Engl] 1998; 111:453-456.
16. 16 Nakamuta M, Ohashi M, Fukutomi T, Tanabe Y, Hiroshige K, Nakashima O, et al. Oral contraceptive-dependent growth of focal nodular hyperplasia. J Gastroenterol Hepatol 1994; 9:521-523.
17. 17 Scott LD, Katz AR, Duke JH, Cowan DF, Maklad NF. Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver. JAMA 1984; 251:1461-1463.
18. 18 Weimann A, Mossinger M, Fronhoff K, Nadalin S, Raab R. Pregnancy in women with observed focal nodular hyperplasia of the liver. Lancet 1998; 351:1251-1252.